Literature DB >> 18314587

Selection of recombinant antibodies from antibody gene libraries.

Michael Hust1, Stefan Dübel, Thomas Schirrmann.   

Abstract

After the sequencing of the human genome is completed, the research focus shifts toward the analysis of gene products. The human genome encodes more than 30,000 genes. Owing to alternative mRNA splicing and posttranslational modifications, for example, glycosylation, phoshorylation, and so on, the number of different proteins of human proteome is supposed to easily exceed 90,000. Antibodies are key detection reagents for the "postgenomic" analysis of these proteins. Any systematic investigation of the human proteome requires high throughput methods for antibody generation. In vitro selection systems utilizing recombinant antibody repertoires offer this capability and capacity. The most commonly used contemporary in vitro selection system is antibody phage display, which has already yielded thousands of useful antibodies for therapy, research, and diagnostics. Herein, methods are described for the selection of recombinant antibody fragments from naive antibody gene libraries.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18314587     DOI: 10.1007/978-1-59745-547-3_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Non-human primate immune libraries combined with germline humanization: an (almost) new, and powerful approach for the isolation of therapeutic antibodies.

Authors:  Thibaut Pelat; Philippe Thullier
Journal:  MAbs       Date:  2009-07-05       Impact factor: 5.857

2.  Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.

Authors:  Carolin Sellmann; Achim Doerner; Christine Knuehl; Nicolas Rasche; Vanita Sood; Simon Krah; Laura Rhiel; Annika Messemer; John Wesolowski; Mark Schuette; Stefan Becker; Lars Toleikis; Harald Kolmar; Bjoern Hock
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

3.  Recombinant antibody fragments allow repeated measurements of C-reactive protein with a quartz crystal microbalance immunosensor.

Authors:  Laila Al-Halabi; Anne Balck; Monika Michalzik; David Fröde; Stephanus Büttgenbach; Michael Hust; Thomas Schirrmann; Stefan Dübel
Journal:  MAbs       Date:  2012-12-06       Impact factor: 5.857

4.  Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity.

Authors:  Thibaut Pelat; Michael Hust; Martha Hale; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2009-06-30       Impact factor: 2.563

5.  Rise and fall of an anti-MUC1 specific antibody.

Authors:  Holger Thie; Lars Toleikis; Jiandong Li; Reinhard von Wasielewski; Gunther Bastert; Thomas Schirrmann; Isabel Tourais Esteves; Christian K Behrens; Bénédict Fournes; Nathalie Fournier; Christophe de Romeuf; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

6.  Suppression of p75 neurotrophin receptor surface expression with intrabodies influences Bcl-xL mRNA expression and neurite outgrowth in PC12 cells.

Authors:  Congcong Zhang; Saskia Helmsing; Marta Zagrebelsky; Thomas Schirrmann; Andrea L J Marschall; Manuela Schüngel; Martin Korte; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

7.  Generation and analysis of the improved human HAL9/10 antibody phage display libraries.

Authors:  Jonas Kügler; Sonja Wilke; Doris Meier; Florian Tomszak; André Frenzel; Thomas Schirrmann; Stefan Dübel; Henk Garritsen; Björn Hock; Lars Toleikis; Mark Schütte; Michael Hust
Journal:  BMC Biotechnol       Date:  2015-02-19       Impact factor: 2.563

8.  Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus.

Authors:  Mark Schütte; Philippe Thullier; Thibaut Pelat; Xenia Wezler; Philip Rosenstock; Dominik Hinz; Martina Inga Kirsch; Mike Hasenberg; Ronald Frank; Thomas Schirrmann; Matthias Gunzer; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

9.  Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV).

Authors:  Martina Inga Kirsch; Birgit Hülseweh; Christoph Nacke; Torsten Rülker; Thomas Schirrmann; Hans-Jürgen Marschall; Michael Hust; Stefan Dübel
Journal:  BMC Biotechnol       Date:  2008-09-02       Impact factor: 2.563

10.  Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.

Authors:  Maria Trott; Svenja Weiβ; Sascha Antoni; Joachim Koch; Hagen von Briesen; Michael Hust; Ursula Dietrich
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.